Philip Went

6.4k total citations · 2 hit papers
86 papers, 4.7k citations indexed

About

Philip Went is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip Went has authored 86 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 36 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip Went's work include Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (8 papers). Philip Went is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (8 papers). Philip Went collaborates with scholars based in Switzerland, Italy and Austria. Philip Went's co-authors include Stephan Dirnhofer, Alexandar Tzankov, Stefano Pileri, Guido Sauter, Alessandro Lugli, Martina Mirlacher, Marcel Bundi, Patrick A. Baeuerle, Sandra Meier and S Dirnhofer and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Philip Went

83 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent EpCam protein expression in human carcinomas

2004 671 citations Philip Went, Alessandro Lugli et al. Human Pathology profile →
Nuclear signalling by tumour-associated antigen EpCAM

2009 565 citations Philip Went et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Philip Went	2.4k	1.5k	1.4k	1.1k	700	86	4.7k
Teresa Marafioti	3.3k 1.4×	1.4k 1.0×	3.0k 2.2×	1.9k 1.8×	663 0.9×	167	6.6k
Frederic I. Preffer	2.0k 0.8×	2.0k 1.3×	905 0.7×	2.3k 2.1×	620 0.9×	112	7.0k
Günter Schlimok	3.9k 1.6×	1.8k 1.2×	841 0.6×	817 0.7×	2.1k 3.0×	79	6.4k
Víctor Moreno	3.8k 1.5×	1.8k 1.2×	520 0.4×	847 0.8×	624 0.9×	287	5.5k
Sarah E. Coupland	4.4k 1.8×	2.3k 1.6×	2.7k 2.0×	1.8k 1.7×	676 1.0×	322	10.2k
John Gutheil	2.3k 0.9×	1.1k 0.8×	635 0.5×	404 0.4×	457 0.7×	40	4.2k
Brenda J. Weigel	2.3k 0.9×	1.9k 1.3×	942 0.7×	1.4k 1.3×	688 1.0×	164	5.8k
Brandon Luber	2.5k 1.0×	961 0.7×	774 0.6×	764 0.7×	1.2k 1.8×	40	4.5k
Korinna Jöhrens	1.4k 0.6×	625 0.4×	484 0.4×	748 0.7×	520 0.7×	138	3.2k
Felipe Samaniego	3.2k 1.3×	2.1k 1.4×	3.1k 2.3×	1.2k 1.1×	526 0.8×	217	7.3k

Countries citing papers authored by Philip Went

Since Specialization

Citations

This map shows the geographic impact of Philip Went's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Went with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Went more than expected).

Fields of papers citing papers by Philip Went

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Went. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Went. The network helps show where Philip Went may publish in the future.

Co-authorship network of co-authors of Philip Went

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Went. A scholar is included among the top collaborators of Philip Went based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Went. Philip Went is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trama, Annalisa, Alice Bernasconi, Adela Cañete, et al.. (2024). Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study. European Journal of Cancer. 214. 115147–115147.

Went, Philip, et al.. (2020). Profound and durable responses with PD-1 immune checkpoint inhibitors in patients with metastatic penile squamous cell carcinoma. SHILAP Revista de lepidopterología. 3. 100045–100045. 3 indexed citations

Went, Philip, et al.. (2020). A Rare Case of Breast Malignancy in an Adolescent Woman: Lessons Learned from Diagnosis and Management. Breast Care. 16(5). 539–543.

Piccaluga, Pier Paolo, Maura Rossi, Claudio Agostinelli, et al.. (2014). Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. Leukemia. 28(8). 1687–1697. 30 indexed citations

Soldini, Davide, Peter J. Schüffler, V. Martin, et al.. (2012). A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Annals of Oncology. 24(1). 193–201. 15 indexed citations

Muenst, Simone, Svenja Thies, Philip Went, et al.. (2011). Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study. Human Pathology. 42(12). 1849–1854. 28 indexed citations

Hoeller, Sylvia, Michel Bihl, Deborah Zihler, et al.. (2011). Molecular and immunohistochemical characterization of B-cell lymphoma-2–negative follicular lymphomas. Human Pathology. 43(3). 405–412. 5 indexed citations

Hoeller, Sylvia, Alexandar Tzankov, Stefano Pileri, Philip Went, & Stephan Dirnhofer. (2009). Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Human Pathology. 41(3). 352–357. 101 indexed citations

Decker, Michael D. & Philip Went. (2008). Placental barrier in acute myeloid leukaemia. British Journal of Haematology. 145(5). 553–553. 3 indexed citations

10.

Piccaluga, Pier Paolo, Claudio Agostinelli, Andrea Califano, et al.. (2007). Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. Journal of Clinical Investigation. 117(3). 823–834. 212 indexed citations

11.

Dirnhofer, Stephan, Philip Went, & André Tichelli. (2007). Diagnostic Problems in Follow-Up Bone Marrow Biopsies of Patients Treated for Acute and Chronic Leukaemias and MDS. Pathobiology. 74(2). 115–120. 4 indexed citations

12.

Lawrie, Charles H., Teresa Marafioti, Christian S. R. Hatton, et al.. (2006). Cancer‐associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. International Journal of Cancer. 118(12). 3161–3166. 34 indexed citations

13.

Karube, Kennosuke, K Ohshima, Junji Suzumiya, et al.. (2005). 2. Biology of Hodgkin's Disease. Annals of Oncology. 16. v83–v85. 1 indexed citations

14.

Went, Philip, et al.. (2005). Placental site trophoblastic tumor of the mediastinum. Human Pathology. 36(5). 581–584. 7 indexed citations

15.

Obermann, Ellen C., Philip Went, Annette Zimpfer, et al.. (2005). Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis. BMC Cancer. 5(1). 162–162. 34 indexed citations

16.

Went, Philip, et al.. (2004). Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen: Eine Gewebe-Mikroarray-Studie an über 600 Non-Hodgkin-Lymphomen. DMW - Deutsche Medizinische Wochenschrift. 129(40). 2094–2099. 1 indexed citations

17.

Lugli, Alessandro, et al.. (2004). Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 444(3). 264–268. 11 indexed citations

18.

Tzankov, Alexandar, Annette Zimpfer, Philip Went, et al.. (2004). Aberrant expression of cell cycle regulators in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma. Modern Pathology. 18(1). 90–96. 46 indexed citations

19.

Went, Philip, et al.. (2004). Expression of Epithelial Cell Adhesion Molecule (EpCam) in Renal Epithelial Tumors. The American Journal of Surgical Pathology. 29(1). 83–88. 77 indexed citations

20.

Frischhut, B., et al.. (1996). Die subkapitale Osteotomie nach Magerl zur Behandlung des Hallux valgus. Der Orthopäde. 25(4). 317–323. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact